Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Down syndrome
Biotech
Ionis scraps Alzheimer's candidate for people with Down syndrome
The decision marks another setback for a group of patients who are both at higher risk for the disease and not served by currently approved therapies.
Darren Incorvaia
Feb 20, 2026 1:50pm
'The Top Line': The year in biotech
Dec 22, 2023 7:00am
New Down syndrome mouse model may be better fit for drug studies
Mar 16, 2023 9:25am
Alzheimer's meds are here, but not for Down syndrome patients
Mar 1, 2023 9:25am
Hormone that may improve cognition in Down syndrome identified
Sep 2, 2022 1:53pm
How Down syndrome genes might protect against solid tumors
Aug 10, 2020 11:39am